ShapeTX logo

ShapeTX

shapetx.com

Facts

Sectors
Biotechnology, Gene therapy, Biopharmaceuticals
Founded
2018

Is this your organization? Claim it

By ShapeTX

ShapeTX CEO Francois Vigneault Says Generative AI Will Drive Programmable RNA Medicines, Enabling Targeted, Durable Therapies

ShapeTX CEO Francois Vigneault discusses using generative AI to design programmable RNA medicines that repair disease-causing genetic mutations, aiming to make treatments faster, more targeted, and less costly. The conversation covers differences from CRISPR and mRNA vaccines, AI-driven drug discovery, targeted AAV delivery to reduce side effects, and durable RNA editing outcomes.

Online